Cite
HARVARD Citation
Young-Xu, Y. et al. (2022). Author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–627. Current medical research and opinion. pp. 2237-2240. [Online].